A New Adderrall Alternative is Now Available: Mydayis

A new drug used to treat attention deficit hyperactivity disorder (ADHD) has been approved by the FDA. It’s called Mydayis and will be manufactured by Shire.

The once-daily medication is meant to last up to 16 hours, by releasing three different types of beads formulated to do so.

Mydayis is a brand alternative to Adderall. The drug is a combination of amphetamine and dextroamphetamine. The drug is a central nervous system stimulant that affects chemicals and nerves that contribute to impulse control and hyperactivity.

Mydayis underwent 16 clinical studies, before it was approved by the FDA. The studies contained more than 1,600 patients with ADHD.

The FDA says Mydayis significantly improved symptoms of ADHD.

“Mydayis is the latest innovation in Shire’s 20-year legacy of helping to support the treatment of ADHD. It’s a testament to Shire’s commitment to helping support the evolving needs of appropriate patients with ADHD,” said Flemming Ornskov, M.D., MPH, CEO of Shire. “With this approval, we hope to help patients who need a once-daily treatment option. Mydayis has shown efficacy lasting up to 16 hours after taking one capsule, beginning at 2 or 4 hours post-dose.”

Will Mydayis lower the price of other ADHD alternatives?

The hope is that as other medications are brought to the market, more competition will be put in place. This, in turn, will ideally lower the cost of all medications related to the treatment. That’s not a given though. Many drug makers will not lower the cost of their branded medications until the drug has either come off patent or a generic version is manufactured.

Mydayis Side Effects

Common side effects of Mydayis include, but are not limited to:

• Trouble sleeping
• Decreased appetite
• Dry mouth
• Increased heart rate
• Anxiety
• Nausea
• Irritability
• Weight loss

You should avoid taking Mydayis if you are allergic to amphetamine or any of the ingredients in Mydayis. You can see a complete list of the ingredients in Mydayis here. You should also avoid taking Mydayis if you are taking, or have taken within the past 14 days, a medicine used to treat depression called a monoamine oxidase inhibitor.

Mydayis contains amphetamine and is a federally controlled substance (CII).

It is important for you to know that amphetamine and dextroamphetamine can be habit-forming. This medicine is known to be used improperly. Before taking this medication, inform your doctor if you have had any problems with drug or alcohol abuse.

Information sourced from a Shire press release announcing Mydayis.